TY - JOUR
T1 - Midfoot Charcot Neuroarthropathy in Patients With Diabetes
T2 - The Impact of Foot Ulceration on Self-Reported Quality of Life
AU - Raspovic, Katherine M.
AU - Hobizal, Kimberlee B.
AU - Rosario, Bedda L.
AU - Wukich, Dane K.
N1 - Funding Information:
None of the authors declare any conflict of interest. The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The project described was supported by the National Institutes of Health through Grant Number UL1TR000005.
Publisher Copyright:
© 2015, © 2015 The Author(s).
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Introduction. Charcot neuroarthropathy (CN) and diabetic foot ulceration (DFU) are serious complications of diabetes mellitus (DM) that can result in infection, hospitalization, amputation, and have been shown to negatively affect quality of life (QOL). To the best of our knowledge, there are no studies in the literature that have specifically compared QOL in patients with diabetic CN without DFU to a group of patients with diabetic CN and concurrent DFU. The aim of this study was to compare self-reported assessments of QOL in patients with CN to a group of patients with CN and concomitant midfoot ulceration. Materials and Methods. We compared a group of 35 diabetic patients with midfoot CN and no ulcer to a group of 22 diabetic patients with midfoot CN and concurrent DFU. Self-reported outcome was assessed using the Medical Outcome Study Short Form 36 (SF-36) health survey and Foot and Ankle Ability Measure (FAAM). Results. No significant differences were found when comparing the 2 groups utilizing the SF-36 and FAAM with the exception that CN patients without foot ulcers had lower mean scores on the Bodily Pain Subscale. Both groups demonstrated negative impact on physical QOL and lower extremity function to a greater degree than mental QOL. Conclusion. The presence of ulceration does not appear to significantly impact QOL in patients with CN when compared to patients with CN without ulceration. Levels of Evidence: Prognostic, Level III: Case control
AB - Introduction. Charcot neuroarthropathy (CN) and diabetic foot ulceration (DFU) are serious complications of diabetes mellitus (DM) that can result in infection, hospitalization, amputation, and have been shown to negatively affect quality of life (QOL). To the best of our knowledge, there are no studies in the literature that have specifically compared QOL in patients with diabetic CN without DFU to a group of patients with diabetic CN and concurrent DFU. The aim of this study was to compare self-reported assessments of QOL in patients with CN to a group of patients with CN and concomitant midfoot ulceration. Materials and Methods. We compared a group of 35 diabetic patients with midfoot CN and no ulcer to a group of 22 diabetic patients with midfoot CN and concurrent DFU. Self-reported outcome was assessed using the Medical Outcome Study Short Form 36 (SF-36) health survey and Foot and Ankle Ability Measure (FAAM). Results. No significant differences were found when comparing the 2 groups utilizing the SF-36 and FAAM with the exception that CN patients without foot ulcers had lower mean scores on the Bodily Pain Subscale. Both groups demonstrated negative impact on physical QOL and lower extremity function to a greater degree than mental QOL. Conclusion. The presence of ulceration does not appear to significantly impact QOL in patients with CN when compared to patients with CN without ulceration. Levels of Evidence: Prognostic, Level III: Case control
KW - Charcot neuroarthropathy
KW - SF-36
KW - diabetic foot ulcer
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=84938328178&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938328178&partnerID=8YFLogxK
U2 - 10.1177/1938640015585957
DO - 10.1177/1938640015585957
M3 - Article
C2 - 25956872
AN - SCOPUS:84938328178
VL - 8
SP - 255
EP - 259
JO - Foot and Ankle Specialist
JF - Foot and Ankle Specialist
SN - 1938-6400
IS - 4
ER -